A step toward the world’s first implantation of an engineered spinal cord
Business Announcement
Updates every hour. Last Updated: 28-Oct-2026 11:16 ET (28-Oct-2026 15:16 GMT/UTC)
Biotech company Matricelf and Loewenstein Rehabilitation Medical Center will collaborate in preparations for the world’s first implantation of an engineered spinal cord in a paralyzed patient. The scientific breakthrough is based on a revolutionary organ-engineering technology developed at TAU by Prof. Tal Dvir of the Sagol Center for Regenerative Biotechnology
Brands that market hemp-derived, intoxicating cannabinoid products are capitalizing on lack of oversight on social media platforms to reach consumers, according to Rutgers Health researchers.
Brands selling intoxicating hemp products such as Delta-8 THC are using memes, cartoons and pop-culture references to market on Instagram while rarely warning about health risks or age limits, according to a new study in the journal Addiction. Nearly half of posts included youth-oriented content. Recreational marketing was widespread. Safety information was rare. Appeals varied by product type. Use of intoxicating hemp products has grown in the United States in recent years, alongside reported poisonings, emergency department visits and psychotic episodes. The study authors note that largely underregulated social media marketing may be contributing to that growth. The findings come at a pivotal moment for federal policy.
Tens of millions of people suffer from traumatic brain injury every year worldwide, with almost 5 million deaths. Yet when it comes to improving clinical outcomes, new research suggests the solution lies far outside hospital operating rooms.
In a randomized clinical trial published in Acta Obstetricia et Gynecologica Scandinavica including 209 pregnant women, participants who followed a strength training program had lower rates of gestational diabetes.
The Foundation for the Accreditation of Cellular Therapy (FACT) and the Joint Assurance Committee of ISCT-and EBMT (JACIE) are pleased to announce that Clínica Ruiz / Centro de Hematología y Medicina Interna in Puebla, Mexico, has become the first program accredited through the FACT-JACIE Accreditation Program of transplant centers in Latin America.